Aminoglycoside nephrotoxicity.
D000617:Aminoglycosides / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000378:metabolism; D001692:Biological Transport; D002511:Cephalosporins / Q000009:adverse effects; D004058:Diffusion; D004357:Drug Synergism; D004798:Enzymes / Q000652:urine; D005839:Gentamicins / Q000009:adverse effects; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007671:Kidney Concentrating Ability / Q000187:drug effects; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000187:drug effects; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D011507:Proteinuria / Q000139:chemically induced
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004798:Enzymes; D005839:Gentamicins